Scientist/Sr. Scientist, Oligo Chemistry

Posted 1ds ago

Employment Information

Industry
Education
Salary
Experience
Job Type

Report this job

Job expired or something wrong with this job?

Job Description

Scientist/Sr. Scientist in Oligonucleotide Chemistry leading oligonucleotide discovery programs. Collaborate with cross-functional teams for therapeutic oligonucleotides development.

Responsibilities:

  • Design and optimize chemically modified oligonucleotides, including siRNAs, ASOs, PMOs, and other emerging modalities.
  • Develop novel nucleoside analogs, phosphoramidites, backbone chemistries, and oligonucleotide architectures to improve potency, stability, durability, and tissue delivery.
  • Generate and interpret structure-activity relationships (SAR) to guide lead optimization across oligonucleotide chemistries and modification patterns.
  • Design oligonucleotide libraries in collaboration with bioinformatics and biology teams to support cellular and in vivo screening campaigns.
  • Develop synthetic routes for novel oligonucleotide building blocks using modern organic and nucleoside chemistry approaches.
  • Oversee the synthesis, purification, and analytical characterization of oligonucleotides and intermediates, leveraging both internal capabilities and external CRO partners.
  • Manage external CROs, including experimental design, prioritization, technical oversight, data review, timeline management, and troubleshooting to ensure high-quality and timely project execution.
  • Develop and apply analytical methods, including RP-HPLC, IEX, LC-MS, CE, and SEC, to characterize oligonucleotides and support process development.
  • Partner closely with biology, pharmacology, toxicology, and translational sciences teams to understand how chemical modifications impact biological activity and therapeutic performance.
  • Contribute to next-generation oligonucleotide platform technologies, including novel chemistries, delivery strategies, and manufacturability improvements.
  • Evaluate emerging technologies and scientific literature to identify innovative approaches that enhance potency, extrahepatic delivery, durability, and safety.
  • Maintain thorough technical documentation and effectively communicate experimental strategies, results, and recommendations to cross-functional teams.

Requirements:

  • Ph.D. in Organic Chemistry, Medicinal Chemistry, or a related discipline with 0-6 years of relevant industry experience, or M.S. with 2-8 years of industry experience in oligonucleotide therapeutic development.
  • Extensive hands-on experience in organic synthesis and nucleoside chemistry, including the synthesis and characterization of phosphoramidites or related oligonucleotide building blocks.
  • Demonstrated expertise in therapeutic oligonucleotide chemistry, including siRNA, antisense oligonucleotides, splice-switching oligonucleotides, PMOs, or related modalities.
  • Possess a deep understanding of contemporary oligonucleotide modification patterns, including 2'-O-methyl, 2'-fluoro, LNA, cEt, constrained analogs, phosphorothioate stereochemistry, phosphodiester incorporation, glycol nucleic acids, morpholino chemistry, and other emerging chemistries and how individual modifications influence potency, nuclease resistance, pharmacokinetics, biodistribution, immunostimulation, and toxicity.
  • Direct experience with oligonucleotide synthesis platforms and purification workflows, including automated solid-phase synthesis and preparative HPLC.
  • Strong analytical expertise with LC-MS, RP-HPLC, ion exchange chromatography, capillary electrophoresis, MALDI-TOF, and related characterization techniques.
  • Experience designing and interpreting medicinal chemistry SAR campaigns for oligonucleotide therapeutics.
  • Familiarity with oligonucleotide delivery technologies, including GalNAc conjugates, lipid conjugates, peptide conjugates, antibody-oligonucleotide conjugates, nanoparticles, or other targeted delivery systems is desirable.
  • Experience supporting lead optimization and candidate selection within a drug discovery environment is preferred.

Benefits:

  • Target annual bonus
  • Equity-based compensation
  • Participation in the company’s benefit programs